The purpose of the present invention is to provide a novel delivery means capable of efficiently delivering an active ingredient to target cells. A locally administered liposome unmodified by PEG and devoid of cholesterol, the liposome being composed of dioleoyl phosphatidyl ethanolamine (DOPE), phosphatidylcholine, and a cationic lipid.